PharmaBlock Sciences (Nanjing
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · China · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Xuefu Roadnanjing Hi-tech Zone 10, Nanji...Phone Number
+86 4000255188Website
www.pharmablock.comRevenue
$188.3 MillionStock Symbol
300725Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About PharmaBlock Sciences (Nanjing
PharmaBlock Sciences ( Nanjing ), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of novel building blocks for drug discovery use. With more drug R&D projects adopting the company's products advance from discovery to preclinical and clinical research, even into commercialization, PharmaBlock moved on to build up top notch process R&D capabilities, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. The company is now committed to a more comprehensive and long-term service to valued customers.Explore more
PharmaBlock Sciences (Nanjing Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PharmaBlock Sciences (Nanjing your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if PharmaBlock Sciences (Nanjing has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PharmaBlock Sciences (Nanjing had a recent Job posting/layoffs
Funding: Get notified immidiatlly once PharmaBlock Sciences (Nanjing has new funding data
PharmaBlock Sciences (Nanjing, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PharmaBlock Sciences (Nanjing launches new products
Check out if PharmaBlock Sciences (Nanjing is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at PharmaBlock Sciences (Nanjing
Earning: See what the market has to say on PharmaBlock Sciences (Nanjing recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined PharmaBlock Sciences (Nanjing as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
PharmaBlock Sciences (Nanjing is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PharmaBlock Sciences (Nanjing is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PharmaBlock Sciences (Nanjing.
PharmaBlock Sciences (Nanjing Tech Stack
A closer look at the technologies used by PharmaBlock Sciences (Nanjing
Most Recent Scoops
Project
, according to a front-line source in financial planning, is planning to release a request for proposal (RFP) for initiatives related to financial data compliance within the next three to six months.
Request for Proposal (RFP), Data Management, Data Science, Financial Planning, Compliance, Finance, Financial Strategy
Project
, according to a front-line source in financial planning, is in the midst of initiatives related to treasury and risk management software.
Automation, Accounting, Financial Planning, Financial Systems, Software, Finance, Financial Strategy, Risk
Project
, according to a front-line source in financial planning, is in the midst of initiatives related to budget creation and management.
Financial Planning, Business Finance, Finance, Financial Operations, Financial Strategy
Project
, according to a front-line source in financial planning, has completed initiatives related to investor relation research within the last twelve months.
Spending/Investment, Research & Development, Financial Planning, Search, Finance, Financial Strategy, Investor Relations
Project
Business Intelligence, Financial Planning, Board of Directors, Financial Reporting, Finance, Financial Strategy
PharmaBlock Sciences (Nanjing News & Media
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
ZURICH, July 20, 2026 /PRNewswire/ -- As Europe experienced one of its hottest Junes on record, with prolonged heatwaves reinforcing the urgency of climate action, leaders from the pharmaceutical industry and academia gathered in Zurich for the PharmaBlock's 3rd Green Chemistry Symposium...PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational
Next-Generation Peptide CRDMO Solutions Enabled by a Green and Intelligent Platform for Empowering Global Innovative Drug Development NANJING, China, June 4, 2026 /PRNewswire/ -- PharmaBlock Sciences (Stock Code: 300725.SZ) today announced the commissioning of its first peptide...PharmaBlock Launches Commercial GMP Workshop 503 at Zhejiang Site
NANJING, China, Feb. 18, 2025 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE) has announced the official launch of its commercial GMP Workshop 503 (W503) at PharmaBlock Zhejiang. The new workshop significantly enhances production capacity and further refines the high-standard GMP manufacturing system, along with advanced automation and the lean operation model, thereby bolstering the company's capabilities in late-phase and commercial manufacturing. Addressing IncrPharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award ... - BioSpace
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition - read this article along with other careers information, tips and advice on BioSpace
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding PharmaBlock Sciences (Nanjing
Sign Up For FreeTo access detailed company insights
PharmaBlock Sciences ( Nanjing ), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of novel building blocks for drug discovery us... Read More
